MEI Pharma Inc. Expands Strategy with $100M Litecoin Treasury Initiative and Plans for Future Innovation

Reuters

08/05

<a href="https://laohu8.com/S/MEIP">MEI Pharma</a> Inc. Expands <a href="https://laohu8.com/S/MSTR">Strategy</a> with $100M Litecoin Treasury Initiative and Plans for Future Innovation

MEI Pharma Inc. has announced a significant expansion of its operations by acquiring 929,548 Litecoin $(LTC)$ tokens, launching a $100 million institutional treasury strategy. This initiative, developed with guidance from Litecoin Creator Charlie Lee and crypto investment firm GSR, makes MEI the first U.S.-listed public company to adopt Litecoin as a primary reserve asset. The strategy aims to leverage Litecoin's scalability and reliability as a long-term store of value and operational treasury asset. MEI also plans to explore Litecoin mining activities, reflecting its commitment to innovation in capital structure and financial technology.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250805082856) on August 05, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2557399037"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2557399037\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2557399037?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-05 20:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2557399037","market":"fut","top_or_hot":-1,"title":"MEI Pharma Inc. Expands Strategy with $100M Litecoin Treasury Initiative and Plans for Future Innovation","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/MEIP\">MEI Pharma</a> Inc. Expands <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> with $100M Litecoin Treasury Initiative and Plans for Future Innovation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        MEI Pharma Inc. has announced a significant expansion of its operations by acquiring 929,548 Litecoin <a href=\"https://laohu8.com/S/LTC\">$(LTC)$</a> tokens, launching a $100 million institutional treasury strategy. This initiative, developed with guidance from Litecoin Creator Charlie Lee and crypto investment firm GSR, makes MEI the first U.S.-listed public company to adopt Litecoin as a primary reserve asset. The strategy aims to leverage Litecoin's scalability and reliability as a long-term store of value and operational treasury asset. MEI also plans to explore Litecoin mining activities, reflecting its commitment to innovation in capital structure and financial technology.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250805082856) on August 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MEI Pharma Inc. Expands Strategy with $100M Litecoin Treasury Initiative and Plans for Future Innovation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMEI Pharma Inc. Expands Strategy with $100M Litecoin Treasury Initiative and Plans for Future Innovation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-08-05 20:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/MEIP\">MEI Pharma</a> Inc. Expands <a href=\"https://laohu8.com/S/MSTR\">Strategy</a> with $100M Litecoin Treasury Initiative and Plans for Future Innovation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        MEI Pharma Inc. has announced a significant expansion of its operations by acquiring 929,548 Litecoin <a href=\"https://laohu8.com/S/LTC\">$(LTC)$</a> tokens, launching a $100 million institutional treasury strategy. This initiative, developed with guidance from Litecoin Creator Charlie Lee and crypto investment firm GSR, makes MEI the first U.S.-listed public company to adopt Litecoin as a primary reserve asset. The strategy aims to leverage Litecoin's scalability and reliability as a long-term store of value and operational treasury asset. MEI also plans to explore Litecoin mining activities, reflecting its commitment to innovation in capital structure and financial technology.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250805082856) on August 05, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250805:nNDL2tp4ZP:1","article_id":"2557399037","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2557399037","pubTimestamp":1754395347,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"MEI Pharma Inc. has announced a significant expansion of its operations by acquiring 929,548 Litecoin  tokens, launching a $100 million institutional treasury strategy. This initiative, developed with guidance from Litecoin Creator Charlie Lee and crypto investment firm GSR, makes MEI the first U.S.-listed public company to adopt Litecoin as a primary reserve asset. The strategy aims to leverage Litecoin's scalability and reliability as a long-term store of value and operational treasury asset. MEI also plans to explore Litecoin mining activities, reflecting its commitment to innovation in capital structure and financial technology.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to ge","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4139":"生物科技","MEIP":"MEI Pharma"},"translate_title":"MEI Pharma Inc.通过1亿美元莱特币资金计划和未来创新计划扩大战略","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MEIP":0.9},"content_text":"MEI Pharma Inc. Expands Strategy with $100M Litecoin Treasury Initiative and Plans for Future Innovation\n    \n\n        MEI Pharma Inc. has announced a significant expansion of its operations by acquiring 929,548 Litecoin $(LTC)$ tokens, launching a $100 million institutional treasury strategy. This initiative, developed with guidance from Litecoin Creator Charlie Lee and crypto investment firm GSR, makes MEI the first U.S.-listed public company to adopt Litecoin as a primary reserve asset. The strategy aims to leverage Litecoin's scalability and reliability as a long-term store of value and operational treasury asset. MEI also plans to explore Litecoin mining activities, reflecting its commitment to innovation in capital structure and financial technology.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MEI Pharma Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250805082856) on August 05, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}